Elysia Group
Elysia Group, Ltd. was founded in 2013 with the mission to bridge the gaps between commercial, health economic, and market access teams by generating value for multiple stakeholders. The company employs a rigorous academic approach to create simple, interpretable deliverables that advance commercial strategies. With a small, agile team including PhD modelers and analysts, Elysia supports projects in health economic modeling, database analysis, market access, and literature searches, primarily serving clients in Asia and the United States.
Industries
Nr. of Employees
small (1-50)
Services
Construction of economic models (cost-effectiveness, budget impact, burden of disease) and specialized analyses (market sizing, forecasting, portfolio analysis) to support commercial and payer decisions.
Design and execution of database research using claims and administrative datasets, including protocol writing and IRB approval, to quantify treatment patterns and eligible patient populations.
Development of roadmaps, playbooks, and launch strategies to guide market entry, scaling, and operational planning.
Creation of regional value dossiers by synthesizing global dossiers and performing localized literature searches for epidemiology, treatment patterns, outcomes, and reimbursement context.
Methodological support to solve statistical and modeling problems, including techniques for limited sample sizes and development of bespoke estimation approaches.
Conducting literature searches for publication or internal decision-making, extracting key data, and organizing findings to inform strategy and future studies.
Construction of economic models (cost-effectiveness, budget impact, burden of disease) and specialized analyses (market sizing, forecasting, portfolio analysis) to support commercial and payer decisions.
Design and execution of database research using claims and administrative datasets, including protocol writing and IRB approval, to quantify treatment patterns and eligible patient populations.
Development of roadmaps, playbooks, and launch strategies to guide market entry, scaling, and operational planning.
Creation of regional value dossiers by synthesizing global dossiers and performing localized literature searches for epidemiology, treatment patterns, outcomes, and reimbursement context.
Methodological support to solve statistical and modeling problems, including techniques for limited sample sizes and development of bespoke estimation approaches.
Conducting literature searches for publication or internal decision-making, extracting key data, and organizing findings to inform strategy and future studies.
Expertise Areas
- Health economic modeling
- Claims and administrative database analysis (including national health insurance datasets)
- Market access and payer strategy
- Value dossier development and localization
Key Technologies
- Cost-effectiveness modeling
- Budget-impact modeling
- Markov models
- Monte Carlo simulation
News & Updates
Join the Elysia Team
Elysia is committed to innovation and excellence in healthcare and technology, seeking talented individuals to drive change and deliver value. They invite interested professionals to connect for future opportunities.
About Us
Elysia Group, Ltd. was formed in 2013 to bridge the gaps between commercial, health economic, and market access teams, focusing on generating value and supporting projects with a rigorous academic approach.
Our Background & Mission
The company aims to support stakeholders with simple, interpretable deliverables that advance commercial strategies, supported by a team including PhD modelers and experts in economics and clinical practice.
Managing Director - Bruce Wang, PhD
Bruce Wang, PhD, is a Co-Founder and CEO, with expertise in modeling and economic models. He has held positions at University of Washington, Alliance Life Sciences, Taipei Medical University, Goldman Sachs, and holds a PhD in Economics from the University of Washington.
Partnership Experts
The company collaborates with experts like Lou Garrison, Jennifer King, and Chao-Hsiun Tang, who have extensive backgrounds in health economics, market access, and health policy.
Join the Elysia Team
Elysia is committed to innovation and excellence in healthcare and technology, seeking talented individuals to drive change and deliver value. They invite interested professionals to connect for future opportunities.
About Us
Elysia Group, Ltd. was formed in 2013 to bridge the gaps between commercial, health economic, and market access teams, focusing on generating value and supporting projects with a rigorous academic approach.
Our Background & Mission
The company aims to support stakeholders with simple, interpretable deliverables that advance commercial strategies, supported by a team including PhD modelers and experts in economics and clinical practice.
Managing Director - Bruce Wang, PhD
Bruce Wang, PhD, is a Co-Founder and CEO, with expertise in modeling and economic models. He has held positions at University of Washington, Alliance Life Sciences, Taipei Medical University, Goldman Sachs, and holds a PhD in Economics from the University of Washington.
Partnership Experts
The company collaborates with experts like Lou Garrison, Jennifer King, and Chao-Hsiun Tang, who have extensive backgrounds in health economics, market access, and health policy.